Results 301 to 310 of about 14,337,199 (401)

Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients. [PDF]

open access: yesClin Kidney J
Tydén M   +12 more
europepmc   +1 more source

The Vulnerable Phase of Heart Failure [PDF]

open access: yes, 2018
Butler, Javed   +5 more
core   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu   +11 more
wiley   +1 more source

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

open access: bronze, 2000
Emmanuelle Vermès   +6 more
openalex   +1 more source

Distinct microbial and metabolic shifts characterize acute coronary syndrome and recovery

open access: yesiMeta, EarlyView.
This study explores the gut–heart axis in coronary artery disease (CAD) using multi‐omics integration of clinical, microbiome and metabolome data. Across healthy controls, stable CAD (sCAD), acute coronary syndrome (ACS), and recovery, we identify stage‐specific microbial dysbiosis and metabolite alterations that mark the transition from stability to ...
Jing Xu   +37 more
wiley   +1 more source

Treatment with oxfendazole increased levels of cardiac troponin I in pigs naturally infected with Taenia solium cysticercosis. [PDF]

open access: yesPLoS One
Zulu C   +10 more
europepmc   +1 more source

Comparative Evaluation of Centrifugation Speed and Its Impact on Diagnostic Accuracy

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study evaluates whether high‐speed centrifugation (5 min at 4000 g) can effectively reduce laboratory turnaround time (TAT) without compromising diagnostic accuracy. Results showed that most analytes remained clinically reliable, hemolysis rates were significantly reduced, and the faster method proved to be a safe and efficient alternative for ...
Mohammed A. Jeraiby   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy